Ghisallo Capital Management LLC Makes New $368,000 Investment in Sera Prognostics, Inc. $SERA

Key Points

• Ghisallo Capital Management LLC has made a new investment of approximately $368,000 in Sera Prognostics, acquiring 100,000 shares and holding about 0.27% of the company.
• CEO Zhenya Lindgardt sold 23,042 shares of Sera Prognostics for approximately $32,950, representing a 2.66% decrease in their ownership.
• Sera Prognostics recently reported an earnings per share (EPS) of ($0.16), surpassing analysts' expectations, while the stock trades at around $3.23 with a market capitalization of $121.67 million.

Ghisallo Capital Management LLC acquired a new position in Sera Prognostics, Inc. (NASDAQ:SERA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 100,000 shares of the company's stock, valued at approximately $368,000. Ghisallo Capital Management LLC owned about 0.27% of Sera Prognostics as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Aberdeen Group plc acquired a new stake in shares of Sera Prognostics in the 1st quarter worth $4,563,000. Nuveen LLC purchased a new stake in Sera Prognostics in the first quarter valued at about $138,000. XTX Topco Ltd acquired a new stake in Sera Prognostics in the first quarter worth about $39,000. Perkins Capital Management Inc. purchased a new stake in shares of Sera Prognostics during the first quarter worth about $522,000. Finally, Bank of New York Mellon Corp increased its holdings in shares of Sera Prognostics by 3.6% during the first quarter. Bank of New York Mellon Corp now owns 135,582 shares of the company's stock valued at $499,000 after acquiring an additional 4,670 shares in the last quarter. Hedge funds and other institutional investors own 54.64% of the company's stock.

Insider Activity at Sera Prognostics

In other news, CEO Zhenya Lindgardt sold 23,042 shares of the stock in a transaction on Monday, June 9th. The shares were sold at an average price of $1.43, for a total value of $32,950.06. Following the sale, the chief executive officer owned 844,209 shares in the company, valued at $1,207,218.87. This represents a 2.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders have sold 44,014 shares of company stock valued at $68,588. 13.50% of the stock is owned by corporate insiders.

Sera Prognostics Stock Performance

Shares of SERA stock opened at $3.23 on Friday. Sera Prognostics, Inc. has a fifty-two week low of $1.37 and a fifty-two week high of $9.13. The firm has a market capitalization of $121.67 million, a PE ratio of -3.80 and a beta of 0.99. The stock's 50-day simple moving average is $2.66 and its 200-day simple moving average is $2.92.

Sera Prognostics (NASDAQ:SERA - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.21) by $0.05. Sera Prognostics had a negative return on equity of 45.86% and a negative net margin of 30,306.48%.The firm had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.05 million. Sell-side analysts forecast that Sera Prognostics, Inc. will post -0.96 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Sera Prognostics from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.

Want to see what other hedge funds are holding SERA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sera Prognostics, Inc. (NASDAQ:SERA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.